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Abstract: Fluoride has been implicated as a pathologic mediator of ﬂuorosis. Interestingly neuronal destruction, synaptic
injury occurs by a mechanism involving oxidative stress, however, its eﬀects in developmental stages of life, during maternal
ﬂuoride exposure and amelioration are not elucidated. In the present study, pregnant Wistar albino rats were exposed to
50 and 150 ppm ﬂuoride in drinking water during gestation and post gestation. After parturition the pups born to the
experimental animals were administered daily with selected antioxidants for 21 consecutive days. Fluoride administration
substantially enhanced ﬂuoride accumulation, lipid peroxidation and decreased the activity of superoxide dismutase, cata-
lase, glutathione peroxidase, glutathione-S-transferase and glutathione levels in discrete regions of central nervous system.
The results signiﬁcantly (P < 0.05) demonstrated the eﬀect of ﬂuoride through exacerbated oxidative damage and disrupted
antioxidant homeostasis, leading to altered neuronal integrity. The administration of antioxidants vitamin E, vitamin C, se-
lenium and zinc produced a promising accost and timely intervention to the aggravated impairment during highly vulnerable
early stage of life.
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Introduction
Chronic ﬂuorosis is prevalent in many parts of the
world, caused by excessive ingestion of ﬂuoride over
prolonged period and endangers the health of humans
and animals (Zhan et al. 2005). High exposure to ﬂu-
oride may occur from natural (drinking water, vegeta-
bles and fruits from endemic areas) and industrial (ﬂu-
orine emission) sources and/or from the misuse of ﬂu-
oride containing dental care products or drugs (Borke
& Whitford 1999; Ozsvath 2009). The WHO guideline
value for ﬂuoride is 1.5 ppm and concentrations beyond
this value carry an increased risk of dental/skeletal
and/or soft tissue ﬂuorosis. Following ingestion, ﬂuo-
ride accumulates in bones and teeth, disperses towards
cardiac muscle, liver, brain, kidney and other soft tis-
sues (Shivashankara et al. 2000; Vani & Reddy 2000)
and cause metabolic disturbances (Chirumari & Reddy
2007). In vivo studies conﬁrm that the ﬂuoride ion is
strongly reactive due to its high negative charge den-
sity and alter the distribution of electrons, including
enzymes and membrane transport proteins, thereby af-
fecting the metabolites of many cells, tissues and organs
(Korkmaz 2000). In advanced stages of ﬂuorosis, neu-
rological manifestations such as paralysis of limbs, ver-
tigo, spasticity in extremities and impaired mental acu-
ity are observed in humans (Inkielewicz & Czanowski
2008; Inkielewicz & Krechniak 2004; Mullenix et al.
1995).
As seen in many chronic degenerative diseases, in-
creased production of reactive oxygen species (ROS)
and lipid peroxidation has been considered in pathogen-
esis and recent studies suggest that oxidative stress is
a possible pathologic mediating factor in ﬂuoride toxic-
ity (Birkner et al. 2006; Inkielewicz & Czanowski 2008;
Krechniak & Inkielewicz 2005), but its occurrence in
the developing stages of life during maternal ﬂuoride
exposure is unclear. Exposure to chemical agents dur-
ing early developmental stages of life results in long-
term irreversible consequences with their structure and
function and account for qualitative diﬀerences in age-
related susceptibility (Fu & Ji 2003; Plantin et al. 1987).
Preponderance of studies suggests that uptake, ac-
cumulation, and toxicity of many xenobiotics can be
modiﬁed by dietary factors (Halliwell 2001; Zheng et
al. 2003) and similarly the use of antioxidants and
antioxidant-rich foods are indicated for the manage-
ment of ﬂuorosis (Chinoy & Shah 2004; Susheela &
Bhatnagar 2002). Thus the present study was aimed
to assess the toxic eﬀects of ﬂuoride in developing cen-
tral nervous system (CNS) of rats and to determine the
protective role of antioxidants supplemented.
Material and methods
Animals
Laboratory bred premated albino rats Rattus norvegicus,
Wistar strain obtained from Sri Raghavendra enterprises,
c©2011 Institute of Zoology, Slovak Academy of Sciences
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Bangalore and acclimatized to laboratory conditions (12 h
dark/light, 25 ± 2◦C). Standard rodent pellet diet was given
ad libitum. The animals were maintained in accordance with
the guidelines of National Institute of Nutrition, ICMR Hy-
derabad and approved by the Institutional animal ethical
committee, Bangalore University, Bangalore.
Design
The pregnant rats were sorted into three groups. The con-
trol (I) group (n = 3) was allowed to drink (self) tap water
(< 1.5 ppm F−) and experimental group II (n = 15) & III
(n = 15) were allowed to drink (self) 50 ppm and 150 ppm
F− in water during gestation and post gestation period, re-
spectively (pups were placentally and lactationally exposed
to ﬂuoride toxicity). After parturition (1st day), the experi-
mental animals along with pups were subdivided into vari-
ous antioxidant treatment groups (n = 3 pools). Only pups
were fed freshly prepared extracts of respective antioxidants
(approximately 10–25 µl volume) by oral gavage in water
(w/v) except vitamin E (in olive oil w/v) for 21 consecutive
days with a daily dose/kg body weight shown vitamin C
20 mg (Dietrich et al. 2003), vitamin E 400 µg (Chinoy &
Sharma 1998), zinc 200 µg (Wallwork et al. 1981) and sele-
nium 40 µg (Santhosh Kumar & Selvam 2003). The control
pups were given same volume of tap water to simulate the
physical stress of oral gavage. On post partum 21st day the
pups were sacriﬁced, cerebral cortex, medulla, cerebellum
and spinal cord were excised, homogenates were prepared
in requisite buﬀers and ﬂuoride and oxidative stress marker
were analysed.
Chemicals
Epinephrine and DTNB (Ellman’s reagent) procured from
Sigma-Aldrich Ltd, and other AR grade chemicals from
Merck Ltd were used for the assay.
Biochemical methods
The biochemical estimations were performed spectrophoto-
metrically by the following methods viz Lipid peroxidation
(LPO) by Niehaus & Samuelsson (1968) and Jiang et al.
(1992), Catalase (CAT) by Aebi (1984), Superoxide dismu-
tase (SOD) by Misra & Fridovich (1972), Glutathione per-
oxidase (GSH-Px) by Rotruck et al. (1973), Glutathione-S-
transferase (GST) by Habig et al. (1974), Glutathione(GSH)
by Ellman (1959), proteins by Lowry et al. (1951) and ﬂu-
oride by ion selective electrode method of Inkielewicz et al.
(2003).
Data interpretation and statistical analysis
The results are expressed as mean ± standard error of the
mean (SEM). Data compilation was carried out using SPSS
15.0 software by employing one-way analysis of variance fol-
lowed by Bonferroni post hoc test to compare means be-
tween the diﬀerent treatment groups and P < 0.05 was con-
sidered as statistically signiﬁcant.
Results and discussion
Neuronal tissues are extremely sensitive to free radicals
as they comprise large quantities of phospholipids, fer-
ric ion, lysosomal activities, high energy requirement
and low levels of enzymatic antioxidants like CAT and
SOD (Blaszczyk et al. 2008). Further the developing
brain is more vulnerable to oxidative cellular damage,
since it contains more susceptible proteins (high disul-
ﬁde bonds), lipids (enriched with essential poly unsatu-
rated fatty acids) and nucleic acids through cell pro-
liferation (Floyd 1999; Geeraerts et al. 1986). Alter-
ations in blood brain barrier integrity due to weakened
antioxidant defenses and increased oxidative exposure
may predispose the brain of premature animals to un-
controlled intensiﬁed free radical processes leading to
a condition called oxidative damage, consequently neu-
ronal disorders are resulted. It has been proven that
ﬂuoride may induce such condition resulting excessive
lipid peroxides and suppressed antioxidants and/or en-
zyme levels (Vani & Reddy 2000).
The results of the present study are depicted in Ta-
bles 1–7. As a functional consequence of maternal ﬂu-
oride exposure the levels of ﬂuorine, lipid peroxidation
and antioxidant enzymes were disturbed by showing in-
creased levels of ﬂuorine, LPO and marked decrease in
the activity of CAT, SOD, GSH-Px, GST and GSH lev-
Table 1. Levels of ﬂuoride in diﬀerent regions of central nervous system (µg of F−/g of tissue).
Group Cerebral Cortex Medulla Cerebellum Spinal cord
Control 0.64 ± 0.01 0.40 ± 0.02 0.27 ± 0.01 0.40 ± 0.06
50 PPM F 1.11 ± 0.04 (+74.35)* 1.03 ± 0.03 (+160.34)* 0.98 ± 0.02 (+263.98)* 1.15 ± 0.03 (+189.50)*
50 PPM F + Vitamin-E 1.04 ± 0.01 (+63.35)* 0.96 ± 0.04 (+142.62)* 0.85 ± 0.03 (+216.77)* 1.01 ± 0.03 (+154.20)*
50 PPM F + Vitamin-C 1.06 ± 0.01 (+66.23)* 0.99 ± 0.05 (+150.63)* 0.94 ± 0.02 (+250.31)* 0.97 ± 0.06 (+144.54)*
50 PPM F + Zinc 1.00 ± 0.02 (+56.81)* 0.93 ± 0.04 (+135.44)* 0.83 ± 0.03 (+209.94)* 0.95 ± 0.03 (+139.50)*
50 PPM F + Selenium 1.04 ± 0.01 (+63.87)* 0.93 ± 0.02 (+134.18)* 0.89 ± 0.03 (+231.68)* 0.96 ± 0.08 (+140.76)*
150 PPM F 2.86 ± 0.02 (+349.48)* 2.58 ± 0.04 (+553.16)* 2.05 ± 0.05 (+664.60)* 2.35 ± 0.04 (+491.60)*
150 PPM F + Vitamin-E 2.72 ± 0.04 (+326.96)* 2.44 ± 0.03 (+518.57)* 1.94 ± 0.04 (+621.74)* 2.26 ± 0.04 (+468.49)*
150 PPM F + Vitamin-C 2.75 ± 0.03 (+332.20)* 2.41 ± 0.03 (+508.86)* 1.96 ± 0.04 (+629.19)* 2.20 ± 0.06 (+453.36)*
150 PPM F + Zinc 2.64 ± 0.02 (+313.87)*† 2.39 ± 0.03 (+504.22)* 1.91 ± 0.04 (+610.56)* 2.19 ± 0.04 (+452.52)*
150 PPM F + Selenium 2.70 ± 0.02 (+323.82)*† 2.42 ± 0.04 (+512.66)* 1.94 ± 0.08 (+621.12)* 2.28 ± 0.06 (+475.21)*
Explanations: Values represent mean levels (n = 6) ± SEM of 6 observations. Values in parentheses indicate % change, ‘+’ sign
indicates increase over controls; * P < 0.05 in comparison to control group. †P < 0.05 in comparison to respective ﬂuoride group.
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Table 2. Activity Levels of LPO in diﬀerent regions of central nervous system (nmol of MDA/mg of tissue).
Group Cerebral Cortex Medulla Cerebellum Spinal cord
Control 1.93 ± 0.02 1.61 ± 0.02 1.94 ± 0.05 1.25 ± 0.03
50 PPM F 2.11 ± 0.01 (+9.24)* 1.86 ± 0.05 (+15.22)* 2.06 ± 0.05 (+6.09) 1.43 ± 0.06 (–14.10)
50 PPM F + Vitamin-E 1.93 ± 0.02 (–0.26)† 1.72 ± 0.08 (+6.23) 1.95 ± 0.05 (+0.17) 1.23 ± 0.05 (–1.99)
50 PPM F + Vitamin-C 2.06 ± 0.02 (+6.74)* 1.66 ± 0.07 (+2.90) 1.98 ± 0.07 (+1.80) 1.27 ± 0.04 (+1.60)
50 PPM F + Zinc 1.96 ± 0.01 (+0.93)† 1.63 ± 0.05 (+0.93) 1.97 ± 0.04 (+1.29) 1.24 ± 0.04 (–1.06)
50 PPM F + Selenium 2.07 ± 0.01 (+6.99)* 1.74 ± 0.03 (+8.28) 2.00 ± 0.05 (+3.09) 1.28 ± 0.05 (+2.39)
150 PPM F 2.55 ± 0.03 (+32.12)* 2.22 ± 0.04 (+38.10)* 2.34 ± 0.04 (+20.69)* 1.61 ± 0.08 (+28.32)*
150 PPM F + Vitamin-E 2.19 ± 0.02 (+13.39)*† 2.10 ± 0.04 (+30.12)* 2.19 ± 0.04 (+12.70)* 1.46 ± 0.06 (+16.09)
150 PPM F + Vitamin-C 2.34 ± 0.02 (+20.98)*† 2.07 ± 0.08 (+28.26)* 2.24 ± 0.03 (+15.19)* 1.49 ± 0.05 (+19.02)
150 PPM F + Zinc 2.15 ± 0.01 (+11.57)*† 2.05 ± 0.08 (+27.54)* 2.22 ± 0.06 (+14.33)* 1.43 ± 0.05 (+13.70)
150 PPM F + Selenium 2.31 ± 0.01 (+19.86)*† 2.12 ± 0.06 (+31.57)* 2.20 ± 0.05 (+13.48)* 1.52 ± 0.05 (+21.28)
Explanations: Values represent mean levels (n = 6) ± SEM of 6 observations. Values in parentheses indicate % change, ‘+’ sign
indicates increase over controls; * P < 0.05 in comparison to control group. †P < 0.05 in comparison to respective ﬂuoride group.
Table 3. Activity of catalase in diﬀerent regions of central nervous system (µmol/min/mg protein).
Group Cerebral Cortex Medulla Cerebellum Spinal cord
Control 125.77 ± 4.69 119.36 ± 5.63 125.21 ± 2.14 126.24 ± 3.38
50 PPM F 103.55 ± 6.74 (–17.67) 101.06 ± 4.30 (–15.34)* 107.76 ± 2.35 (–13.94)* 108.34 ± 3.50 (–14.17)*
50 PPM F + Vitamin-E 117.71 ± 5.13 (–6.41) 112.40 ± 3.09 (–5.84) 114.93 ± 3.78 (–8.21) 117.88 ± 4.72 (–6.62)
50 PPM F + Vitamin-C 122.12 ± 6.79 (–2.90) 109.95 ± 5.68 (–7.89) 115.22 ± 2.50 (–7.28) 119.02 ± 3.78 (–5.72)
50 PPM F + Zinc 122.88 ± 2.56 (–2.30) 116.05 ± 3.51 (–2.77) 119.19 ± 3.34 (–4.81) 124.03 ± 2.08 (–1.75)
50 PPM F + Selenium 116.41 ± 4.78 (–7.45) 110.12 ± 2.97 (–7.75) 110.92 ± 3.36 (–11.41)* 117.53 ± 4.48 (–6.89)
150 PPM F 92.22 ± 4.22 (–26.68)* 80.46 ± 4.50 (–32.59)* 79.82 ± 1.63 (–36.25)* 82.35 ± 2.45 (–34.76)*
150 PPM F + Vitamin-E 113.30 ± 4.04 (–9.92) 101.12 ± 4.17 (–15.28)* 99.60 ± 3.67 (–20.45)*† 98.81 ± 2.47 (–21.73)*
150 PPM F + Vitamin-C 116.97 ± 5.52 (–7.00) 98.85 ± 1.59 (–17.18)* 100.48 ± 2.87 (–19.75)*† 99.85 ± 2.62 (–20.90)*†
150 PPM F + Zinc 117.11 ± 5.37 (–6.89) 102.89 ± 1.97 (–13.80)*† 102.54 ± 3.32 (–18.10)*† 100.21 ± 1.64 (–20.62)*†
150 PPM F + Selenium 112.20 ± 6.11 (–10.79) 98.30 ± 1.64 (–17.65)* 97.70 ± 4.67 (–21.97)*† 96.23 ± 3.00 (–23.77)*
Explanations: Values represent mean levels (n = 6) ± SEM of 6 observations. Values in parentheses indicate % change, ‘–’ sign indicates
decrease over controls; * P < 0.05 in comparison to control group. †P < 0.05 in comparison to respective ﬂuoride group.
els signiﬁcantly (P < 0.05) in discrete regions of CNS
studied.
The present study demonstrated the perturbed an-
tioxidant system on exposure to ﬂuoride. The increased
level of ﬂuoride in the discrete regions of CNS noticed
in the present study might be due to the immaturity of
the organ systems, especially the excretory system and
the failure of blood brain barrier in excluding ﬂuoride
ion from the nervous tissue (Floyd 1999), however, the
dietary supplementation of antioxidants played a criti-
cal role in diminishing the rate of ﬂuoride accumulation
by augmenting the altered antioxidant defense and sup-
pressing the oxidant devastation.
The maternal ﬂuoride exposure exhibited a signif-
icant (P < 0.05) increase in LPO as evidenced by in-
crease in MDA levels, further the decreased activity of
antioxidant enzymes CAT, SOD, GSH-Px, GST and
GSH levels in discrete regions of CNS indicate imbal-
ance in the equilibrium among factors that promote free
radical formation and the antioxidant defense mecha-
nisms, leading oxidative stress. The decreased activities
of CAT and SOD (major intracellular antioxidant en-
zymes) are in response to increased production of H2O2
and O2. Hydrogen peroxide, a reaction product of the
superoxide dismutation reaction, inactivates SOD and
in the presence of hydrogen peroxide SOD acts as a
prooxidant (Rafalowska et al. 1995). Moreover, the de-
creased activity of GSH-Px and GST indicate the ex-
tent of cellular damage caused by the LPO and inabil-
ity of GSH-Px enzyme in checking the damage. This
interaction of reactive oxygen species (ROS) can aﬀect
signiﬁcantly cell proliferation, diﬀerentiation and mem-
brane mediated lipid neurotransmitter signal transduc-
tion mechanisms during early development (Halliwell
1989).
Among the discrete regions studied spinal cord
was highly aﬀected by showing increased LPO and
decreased antioxidant enzyme levels in both dosage
groups. The observed diﬀerences in the level of LPO
products and antioxidant enzymes in various regions
may be due to the diﬀerences in their iron, selenium,
copper, zinc, manganese content and also in their oxy-
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Table 4. Activity of SOD in diﬀerent regions of central nervous system (µmol/min/mg protein).
Group Cerebral Cortex Medulla Cerebellum Spinal cord
Control 4.66 ± 0.14 3.56 ± 0.12 3.31 ± 0.04 2.49 ± 0.05
50 PPM F 3.64 ± 0.17 (–22.02)* 3.22 ± 0.03 (–9.56)* 3.07 ± 0.02 (–7.34) 1.92 ± 0.14 (–23.06)*
50 PPM F + Vitamin-E 4.20 ± 0.06 (–9.83)* 3.36 ± 0.05 (–5.57) 3.23 ± 0.03 (–2.52) 2.30 ± 0.04 (–7.69)†
50 PPM F + Vitamin-C 4.18 ± 0.11 (–10.30)* 3.41 ± 0.09 (–4.22) 3.25 ± 0.07 (–2.01) 2.31 ± 0.03 (–7.49)†
50 PPM F + Zinc 4.34 ± 0.07 (–7.01)† 3.46 ± 0.08 (–2.67) 3.35 ± 0.09 (+1.06) 2.35 ± 0.03 (–5.61)†
50 PPM F + Selenium 4.18 ± 0.05 (–10.30)* 3.40 ± 0.09 (–4.59) 3.30 ± 0.03 (–0.45) 2.26 ± 0.04 (–9.22)*†
150 PPM F 3.08 ± 0.03 (–34.00)* 2.82 ± 0.05 (–20.80)* 2.68 ± 0.05 (19.06)* 1.36 ± 0.04 (–45.45)*
150 PPM F + Vitamin-E 3.83 ± 0.15 (–17.88)*† 3.10 ± 0.07 (–12.79)* 2.86 ± 0.07 (–13.78)* 1.96 ± 0.05 (–21.26)*†
150 PPM F + Vitamin-C 3.87 ± 0.08 (–17.02)*† 3.22 ± 0.04 (–9.56)*† 2.99 ± 0.16 (–9.71)* 1.99 ± 0.03 (–20.19)*†
150 PPM F + Zinc 4.01 ± 0.07 (–14.05)*† 3.25 ± 0.04 (–8.81)*† 3.03 ± 0.05 (–8.70)* 2.04 ± 0.05 (–18.05)*†
150 PPM F + Selenium 3.93 ± 0.10 (–15.73)*† 3.15 ± 0.02 (–11.38)* 2.99 ± 0.04 (–9.91)* 2.01 ± 0.03 (–19.52)*†
Explanations: Values represent mean levels (n = 6) ± SEM of 6 observations. Values in parentheses indicate % change, ‘–’ sign indicates
decrease over controls; * P < 0.05 in comparison to control group. †P < 0.05 in comparison to respective ﬂuoride group.
Table 5. Activity of GSH-Px in diﬀerent regions of central nervous system (µg of GSH consumed/min/mg protein).
Group Cerebral Cortex Medulla Cerebellum Spinal cord
Control 3.43 ± 0.04 2.55 ± 0.06 2.46 ± 0.04 2.24 ± 0.03
50 PPM F 3.10 ± 0.03 (–9.71)* 2.35 ± 0.03 (–8.04)* 2.24 ± 0.02 (–8.89)* 2.03 ± 0.03 (–9.32)*
50 PPM F + Vitamin-E 3.32 ± 0.07 (–3.30) 2.50 ± 0.03 (–1.90) 2.40 ± 0.02 (–2.24) 2.24 ± 0.04 (+0.15)†
50 PPM F + Vitamin-C 3.30 ± 0.04 (–3.93) 2.43 ± 0.04 (–4.58) 2.42 ± 0.03 (–1.36) 2.21 ± 0.03 (–1.04)
50 PPM F + Zinc 3.43 ± 0.06 (–0.15)† 2.52 ± 0.03 (–1.24) 2.45 ± 0.03 (–0.14)† 2.22 ± 0.04 (–0.52)
50 PPM F + Selenium 3.40 ± 0.03 (–0.87)† 2.51 ± 0.03 (–1.44) 2.44 ± 0.02 (–0.81)† 2.25 ± 0.02 (+0.75)†
150 PPM F 2.42 ± 0.03 (–29.56)* 1.98 ± 0.03 (–22.48)* 1.76 ± 0.05 (–28.29)* 1.37 ± 0.03 (–38.93)*
150 PPM F + Vitamin-E 2.70 ± 0.04 (–21.50)*† 2.28 ± 0.02 (–10.52)*† 2.15 ± 0.03 (–12.48)*† 1.61 ± 0.02 (–27.82)*†
150 PPM F + Vitamin-C 2.76 ± 0.06 (–19.56)*† 2.31 ± 0.04 (–9.61)*† 2.20 ± 0.04 (–10.31)*† 1.64 ± 0.03 (–26.55)*†
150 PPM F + Zinc 2.89 ± 0.04 (–15.97)*† 2.36 ± 0.04 (–7.45)*† 2.31 ± 0.05 (–5.58)† 1.77 ± 0.03 (–20.95)*†
150 PPM F + Selenium 2.82 ± 0.04 (–18.01)*† 2.34 ± 0.03 (–8.17)* 2.29 ± 0.02 (–6.65)*† 1.74 ± 0.06 (–22.07)*†
Explanations: Values represent mean levels (n = 6) ± SEM of 6 observations. Values in parentheses indicate % change, ‘+’ sign
indicates increase, ‘–’ sign indicates decrease over controls; * P < 0.05 in comparison to control group. †P < 0.05 in comparison to
respective ﬂuoride group.
gen consumption rate, which inﬂuence the production
of ROS (Murali & Panneerselvam 2007). The present
study clearly reveals that excessive accumulation of ﬂu-
oride interfere with structural and functional integrity
of the developing nervous system through generation of
oxidative stress, leading to alter neuronal integrity. Sev-
eral studies (Chirumari & Reddy 2007; Inkielewicz &
Czanowski 2008; Murali & Panneerselvam 2007; Shiv-
ashankara et al. 2000; Vani & Reddy 2000) suggest sim-
ilar results and corroborate the present ﬁndings.
The detoxiﬁcation of xenobiotics lead to natural
deﬁcit of certain vital nutrients/antioxidants and fur-
ther risk caused by the increased environmental insults
that induce oxidative stress. If this natural deﬁcit is
conquered by restoring or maintaining oxidative buﬀer-
ing capacity, it represents a useful therapeutic strategy
to minimize oxidative stress directed neurological disor-
ders. The supplemented antioxidants can interact with
oxidizing radicals directly and protect cells from oxida-
tive stress by limiting tissue damage (Halliwell 1989,
2001; Murali & Panneerselvam 2007; Zheng et al. 2003).
In addition, the fact that the antioxidant enzymes re-
quire micro-nutrients as cofactors such as selenium,
iron, copper, zinc, manganese etc. for optimal catalytic
activity and eﬀective antioxidative defense mechanism
(Halliwell 1989, 2001). Thus supplementation of these
micronutrients might be the novel strategy or nutri-
tive intervention for upholding the ﬂuoride interceded
pathophysiology.
The supplementation of vitamin C and vitamin E
in the present study suggests a protective act by their
synergistic action in minimizing the toxic eﬀect of ﬂu-
oride mediated oxidative stress. Vitamin E, a known
free radical scavenger, most eﬀective in higher con-
centrations of oxygen, major contributor to oﬀer non-
enzymatic protection against lipid peroxidation (Hal-
liwell 1989, 2001). Vitamin E can quench superoxide
radical and lipid peroxide radicals. When vitamin E
quenches free radicals, it becomes a vitamin E radical,
which then uses vitamin C to return it to its antioxidant
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Table 6. Activity of GST in diﬀerent regions of central nervous system (nmol GSH-CDNB formed/mg protein/min).
Group Cerebral Cortex Medulla Cerebellum Spinal cord
Control 85.59 ± 2.33 85.65 ± 2.48 82.93 ± 2.28 67.50 ± 1.73
50 PPM F 66.83 ± 2.37 (–21.92)* 70.46 ± 1.21 (–17.73)* 70.02 ± 1.25 (–15.56)* 52.88 ± 1.04 (–21.66)*
50 PPM F + Vitamin-E 79.19 ± 2.23 (–7.42) 81.86 ± 1.53 (–4.43)† 78.44 ± 1.04 (–5.41)† 64.22 ± 0.99 (–4.86)†
50 PPM F + Vitamin-C 74.57 ± 1.87 (–12.88)* 78.44 ± 2.20 (–8.41) 78.30 ± 0.81 (–5.58)† 64.07 ± 1.81 (–5.09)†
50 PPM F + Zinc 80.27 ± 1.29 (–6.21)† 81.03 ± 1.79 (–5.39)† 80.04 ± 1.79 (–3.48)† 65.65 ± 1.34 (–2.75)†
50 PPM F + Selenium 79.63 ± 3.08 (–6.97)† 78.18 ± 1.45 (–8.72) 81.48 ± 1.35 (–3.48)† 64.58 ± 1.54 (–4.33)†
150 PPM F 47.51 ± 2.05 (–44.49)* 46.58 ± 2.25 (–45.62)* 59.83 ± 1.61 (–27.85)* 33.55 ± 1.10 (–50.30)*
150 PPM F + Vitamin-E 71.07 ± 1.52 (–16.97)*† 64.24 ± 1.85 (–24.99)*† 67.26 ± 1.91 (–18.89)* 50.67 ± 1.99 (–24.94)*†
150 PPM F + Vitamin-C 69.21 ± 2.32 (–19.14)*† 59.81 ± 1.24 (–30.16)*† 67.18 ± 1.65 (–18.99)* 52.53 ± 1.59 (–22.17)*†
150 PPM F + Zinc 72.67 ± 2.23 (–15.09)*† 64.30 ± 1.52 (–24.92)*† 68.77 ± 1.57 (–17.07)*† 54.94 ± 1.09 (–18.60)*†
150 PPM F + Selenium 68.40 ± 1.81 (–20.09)*† 61.06 ± 1.09 (–28.71)*† 65.88 ± 1.14 (–20.56)* 53.21 ± 1.82 (–21.18)*†
Explanations: Values represent mean levels (n = 6) ± SEM of 6 observations. Values in parentheses indicate % change, ‘–’ sign indicates
decrease over controls; * P < 0.05 in comparison to control group. †P < 0.05 in comparison to respective ﬂuoride group.
Table 7. Levels of GSH in diﬀerent regions of central nervous system (mg of GSH/100 g of tissue).
Group Cerebral Cortex Medulla Cerebellum Spinal cord
Control 49.29 ± 1.69 42.35 ± 1.80 42.48 ± 0.88 38.81 ± 1.31
50 PPM F 41.55 ± 1.63 (–15.69)* 31.54 ± 1.21 (–25.53)* 34.61 ± 1.45 (–18.54)* 30.74 ± 1.24 (–20.80)*
50P PM F + Vitamin-E 46.05 ± 0.94 (–6.58) 40.60 ± 1.26 (–4.14)† 40.57 ± 1.59 (–4.50) 35.85 ± 1.50 (–7.64)
50 PPM F + Vitamin-C 46.59 ± 1.41 (–5.47) 41.11 ± 0.93 (–1.37)† 41.90 ± 1.24 (–4.37) 38.18 ± 1.86 (–1.64)
50 PPM F + Zinc 48.89 ± 1.25 (–0.80) 42.13 ± 1.14 (–0.53)† 40.78 ± 1.53 (–4.01) 36.43 ± 1.53 (–6.15)
50 PPM F + Selenium 46.54 ± 1.18 (–5.57) 41.73 ± 1.23 (–1.47)† 40.83 ± 1.12 (–3.90) 36.84 ± 1.80 (–5.09)
150 PPM F 28.82 ± 1.23 (–41.53)* 23.17 ± 0.85 (–45.29)* 20.24 ± 1.45 (–52.35)* 18.80 ± 1.40 (–51.56)*
150 PPM F + Vitamin-E 37.03 ± 0.79 (–24.86)*† 31.71 ± 1.22 (–25.13)*† 31.30 ± 0.58 (–26.33)*† 28.93 ± 1.11 (–25.47)*†
150 PPM F + Vitamin-C 35.96 ± 1.69 (–27.05)* 31.94 ± 1.04 (–24.58)*† 32.07 ± 1.93 (–24.50)*† 31.69 ± 1.02 (–18.34)*†
150 PPM F + Zinc 38.84 ± 0.99 (–21.19)*† 32.32 ± 1.25 (–23.70)*† 33.14 ± 1.08 (–22.00)*† 31.22 ± 1.37 (–19.56)*†
150 PPM F + Selenium 38.75 ± 0.93 (–21.38)*† 32.54 ± 1.70 (–23.18)*† 33.62 ± 1.81 (–20.86)*† 32.21 ± 0.99 (–17.01)*†
Explanations: Values represent mean levels (n = 6) ± SEM of 6 observations. Values in parentheses indicate % change, ‘–’ sign indicates
decrease over controls; * P < 0.05 in comparison to control group. †P < 0.05 in comparison to respective ﬂuoride group.
state (Rikans et al. 1991). Vitamin C is the most ver-
satile antioxidant and a powerful scavenger of hydroxyl
radical and regenerator of vitamin E and the key antiox-
idant glutathione, which reacts enzymatically (through
GSH-Px) and non-enzymatically with a broad range
of oxidants. Studies of Frei et al. (1989) reported that
when plasma lipids were subjected to oxidative stress
they were best protected by vitamin C, and the loss of
vitamin E radicals did not begin until after all vitamin
C was consumed. These synergetic actions of vitamin C
and E favored in the restoration of the upcoming eﬀects
of ﬂuoride arbitrated oxidative stress.
The zinc supplementation showed pronounced re-
covery as a component of Cu-Zn SOD and helps in
converting potentially destructive O−2 to H2O2 (Mu-
rali & Panneerselvam 2007). In addition to preven-
tion of the disrupting eﬀects of lipid peroxidation
and membrane protein-oxidation, zinc also acts to
stabilize membranes through various mechanisms and
promote membrane skeletal/cytoskeletal protein asso-
ciations, blockage of membrane channels caused by
toxins/amphipathic molecules (Bray & Bettger 1990;
Taysi et al. 2008). Further zinc acts to protect pro-
tein thiol groups from oxidation and competes with
prooxidants like iron and copper in diminishing their
oxidation potential. Thus supplementation of zinc
duly eliminate ﬂuoride interceded reactive free radi-
cals.
The present ﬁndings of selenium supplementation
exhibited profound upholding in all the anti/oxidant
parameters studied and maximum noticed in GSH-Px.
These protective eﬀects of selenium seem to be pri-
marily associated with its presence in the GSH-Px and
thioredoxin reductase, which are known to protect DNA
and other cellular components from oxidative dam-
age (Cantin et al. 2007). Generally, seleno-enzymes are
known to play an important role in the control of cell di-
vision, oxygen metabolism, detoxiﬁcation process, addi-
tionally, in vitro studies have shown that selenium com-
pounds are able to inhibit oxidative stress (Schweizer et
al. 2004). The deﬁciency or utilization of selenium dur-
ing ﬂuoride toxicity may markedly decrease antioxidant
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capacity and results in peroxidative damage and mito-
chondrial dysfunction.
In conclusion, ﬂuoride duly proves the possibil-
ity of causing neuronal oxidative stress in early stages
of life during maternal exposure. The administration
of oral antioxidants exhibited a promising therapeutic
approach in minimizing or preventing toxicity indicat-
ing ameliorative role. Among the antioxidants supple-
mented zinc and vitamin E showed maximum amelio-
ration.
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